Balentine LLC Johnson & Johnson Transaction History

Balentine LLC

$3.35 Billion
Q1 2024

A detailed history of Balentine LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Balentine LLC holds 40,685 shares of JNJ stock, worth $5.95 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

40,685

Previous 83,742 51.42%

Holding current value

$5.95 Million

Previous $13.1 Million 50.97%

% of portfolio

0.19%

Previous 0.42%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $6.68 Million - $7.01 Million	-43,057 Reduced 51.42%	40,685 $6.44 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $32,614 - $35,589	224 Added 0.27%	83,742 $13.1 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $276,456 - $309,702	1,775 Added 2.17%	83,518 $13 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $1.51 Million - $1.63 Million	-9,800 Reduced 10.71%	81,743 $13.5 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $4.62 Million - $5.52 Million	-30,600 Reduced 25.05%	91,543 $14.2 Million

Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $2.74 Million - $3.07 Million	17,090 Added 16.27%	122,143 $21.6 Million
Q3 2022 Oct 26, 2022	SELL	$161.33 - $179.52 $4.07 Million - $4.53 Million	-25,237 Reduced 19.37%	105,053 $17.2 Million
Q2 2022 Oct 26, 2022	BUY	$168.19 - $186.01 $10.9 Million - $12.1 Million	64,928 Added 99.34%	130,290 $23.1 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $21.9 Million - $24.2 Million	130,290 New	130,290 $23.1 Million
Q1 2022 Oct 26, 2022	SELL	$158.14 - $179.59 $10.3 Million - $11.7 Million	-64,928 Reduced 49.83%	65,362 $11.6 Million
Q4 2021 Oct 26, 2022	SELL	$155.93 - $173.01 $15.5 Million - $17.2 Million	-99,342 Reduced 76.25%	30,948 $5.29 Million
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $3.49 Million - $3.87 Million	-22,363 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $1.83 Million - $2.03 Million	11,325 Added 102.6%	22,363 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $504,754 - $541,436	3,165 Added 40.2%	11,038 $1.82 Million
Q1 2021 May 10, 2021	BUY	$153.07 - $170.48 $234,044 - $260,663	1,529 Added 24.1%	7,873 $1.29 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $260,509 - $299,022	1,900 Added 42.75%	6,344 $999,000
Q3 2020 Nov 02, 2020	BUY	$140.38 - $153.83 $254,789 - $279,201	1,815 Added 69.04%	4,444 $662,000
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $86,045 - $103,880	-668 Reduced 20.26%	2,629 $370,000
Q1 2020 May 18, 2020	BUY	$111.14 - $153.99 $163,709 - $226,827	1,473 Added 80.76%	3,297 $432,000
Q4 2019 Sep 02, 2020	BUY	$127.5 - $146.44 $50,490 - $57,990	396 Added 27.73%	1,824 $266,000
Q3 2019 Nov 15, 2019	BUY	$126.95 - $142.14 $100,671 - $112,717	793 Added 124.88%	1,428 $185,000
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $80,919 - $88,996	-617 Reduced 49.28%	635 $88,000
Q1 2019 May 16, 2019	SELL	$125.72 - $139.79 $2,137 - $2,376	-17 Reduced 1.34%	1,252 $175,000
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $110,556 - $133,056	900 Added 243.9%	1,269 $164,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $36,352 - $42,721	299 Added 427.14%	369 $51,000
Q1 2018 May 16, 2018	SELL	$125.1 - $148.14 $415,832 - $492,417	-3,324 Reduced 97.94%	70 $9,000
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $439,421 - $459,479	3,394	3,394 $441,000

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account